Arkolith/Insider Trading/IRWD/Form 4

Martini Gregory S.

Chief Financial OfficerIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed Feb 12, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$21K
Net Open-Market Flow
-$21K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 10, 2025Sell(S)12K$1.76$21K184K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-019233) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML